Pharmaceutical - Pharmaceutical, North America, Pricing


1 to 25 of 58 results

Patent lawyer seeking US Senate seat proposes patent reform to lower Rx drug costs


Republican Art Gardner, a patent attorney seeking election to the US Senate in Georgia, has issued a…

North AmericaPatentsPharmaceuticalPoliticsPricingUSA

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing


In further legal action against drugmakers allegedly over pricing AIDS drugs in the USA, the AIDS Healthcare…

Abbott LaboratoriesAbbVieAnti-viralsKaletra TabletsLegalNorth AmericaNorvirPharmaceuticalPricing

AHF sues Johnson & Johnson over AIDS drug pricing

AHF sues Johnson & Johnson over AIDS drug pricing


The Washington DC, USA-based AIDS Healthcare Foundation (AHF) has filed a law suit in the Superior Court…

Anti-viralsJanssenJohnson & JohnsonLegalNorth AmericaPharmaceuticalPricing

US infectious disease specialists’ prescribing choices for GNIs

US infectious disease specialists’ prescribing choices for GNIs


A majority of US surveyed infectious disease specialists are willing to prescribe novel antibiotics if…

Antibiotics and Infectious diseasesMarkets & MarketingNorth AmericaPharmaceuticalPricing

US Senator seeks answers from drugmakers on providing required discounts


US Senator Charles Grassley has written to two drug companies on behalf of an Iowa hospital that is not…

CSL BehringExparelHematologyKcentraNeurologicalNorth AmericaPacira PharmaceuticalsPharmaceuticalPoliticsPricing

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs


The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

Bayer in settlement over Cipro pricing


A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Mixed US views on Gilenya, Aubagio and Tecfidera as breakthrough MS drugs


More than half of surveyed neurologists consider US biotech firm Biogen Idec's (Nasdaq: BIIB) Tecfidera…

AubagioBiogen IdecGilenyaMarkets & MarketingNeurologicalNorth AmericaNovartisPharmaceuticalPricingSanofiTecfidera

Health care reforms not keeping pace with needs of Canadians, says report


The Health Council of Canada today (May 23) released Progress Report 2013: Health care renewal in Canada,…

HealthcareNorth AmericaPharmaceuticalPricing

US Senator Grassley questions continue about 340B discount drug program


US Senator Chuck Grassley (Republican, Iowa) is looking into how hospitals are using a discount prescription…

North AmericaPharmaceuticalPoliticsPricing

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer


The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

High leukemia treatment costs may be harming patients, say experts


The increasing cost of treatments for chronic myeloid leukemia (CML) in the USA has reached unsustainably…

North AmericaOncologyPharmaceuticalPricing

Legislation would undermine USA's Medicare Part D, argues PhRMA


Several members of the US Congress this week echoed President Barack Obama's recycling of a "flawed policy…

HealthcareLegalNorth AmericaPharmaceuticalPricing

US Senator calls for re-examination of pricing of drugs developed with public funds


US Senator Ron Wyden (Democrat, Oregon) has released a letter written to National Institutes of Health…

North AmericaPfizerPharmaceuticalPoliticsPricingResearchXeljanz

Independent US drugstore lobby wants sweeping Antitrust exemptions to charge higher prescription drug prices


The independent drugstore lobby is again seeking special antitrust exemptions (HR 1188) that would empower…

LegalNorth AmericaPharmaceuticalPricing

Unnecessary drug regulations hiking Rx prices in USA: NCPA Study


As drug coverage increases as a result of expanded health insurance and Medicaid coverage under the USA's…

BiotechnologyNorth AmericaPharmaceuticalPricingRegulation

Vivus announces new discount program for obesity drug Qsymia


US drugmaker Vivus (Nasdaq: VVUS) has announced a new program offering eligible patients a discount on…

Markets & MarketingMetabolicsNorth AmericaPharmaceuticalPricingQsymiaVivus

US health care law allows consumers to easily find and compare options, says HHS Secretary


US Department of Health and Human Services (HHS) Secretary Kathleen Sebelius yesterday announced a final…

FinancialHealthcareNorth AmericaPharmaceuticalPricing

Rise in drug costs to US hospitals and clinics slowing in 2013


Although medicine costs will continue to rise in 2013 by as much as 4%, the increase is projected to…

Markets & MarketingNorth AmericaPharmaceuticalPricing

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices


A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

US physician acquiescence to patient demands for brand-name drugs, slammed in JAMA article


Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

Express Scripts finds most used Rx drugs price hikes six times that of overall US inflation


The US Prescription Price Index shows that, since September 2011, price inflation for the most highly…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Survey reveals 98.9% of US physicians experienced cancer drug shortages in last 12 months


The Community Oncology Alliance (COA), a US non-profit organization, announced the results of a drug…

GenericsHealthcareNorth AmericaOncologyPharmaceuticalPricing

Sanofi halves US price of Zaltrap, responding to criticism from oncologists


French drug major Sanofi (Euronext: SAN) has said that it would halve the price of its colorectal cancer…

North AmericaOncologyPharmaceuticalPricingSanofiZaltrap

1 to 25 of 58 results

Back to top